Review clinical trials related to Stent-Graft Endoleak. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.
The goal of this registry is to evaluate the semibranch in branched endovascular arotic repair, which is a new tool in endovascular branched aortic repair.
Patient has been treated with the semibranch stentgraft [+1]
The goal of this registry is to evaluate the semibranch in branched endovascular aortic repair, which is a new tool in endovascular branched aortic repair.
18 years or older [+4]
Women of childbearing age [+1]
The ENDOBARC-S post-market clinical follow-up study is undertaken to evaluate the prevention of death related to aortic arch pathologies when treated by branch stent graft systems (Nexus stent-graft system®, Relay Branch® or Zenith arch branch graft®), with proximal landing at zone 0. The secondary objective is to evaluate the safety and clinical performance of the studied devices.
Patient is between 18 and 90 years old [+3]
Patient less than 18 years old or more than 90 years old. [+8]